Maquet And PULSION Announce Distribution Agreement For The PiCCO® And ProAQT® Hemodynamic Product Lines

WAYNE, N.J., Oct. 7, 2014 /PRNewswire/ -- Maquet Medical Systems announced a collaboration with PULSION Medical Systems wherein Maquet will distribute PULSION's PiCCO hemodynamic monitoring technology and ProAQT perioperative hemodynamic management products. Maquet is the majority shareholder in Pulsion.

"Nearly 1,000 publications worldwide have confirmed the accuracy and clinical benefit of the PiCCO technology, and we're delighted to augment our product portfolio through this distribution agreement," said Raoul Quintero, Regional President and CEO of Maquet Medical Systems USA.  "We are always looking for new ways to ensure we are providing the most innovative technologies and this agreement, combined with our recent acquisitions and continued organic growth, establishes Maquet as a leading provider of comprehensive life support options to patients."   

The PiCCO Technology provides all the necessary information in an easy to interpret graphical visualization, providing clinicians with tools to assist them make therapeutic decisions, based on clear and hard facts. ProAQT visualizes the arterial blood pressure curve providing clinicians with a decision support tool to determine the patient's cardiovascular status and to support decisions regarding clinical interventions.

PiCCO Cardiac Output System monitors hemodynamic function in intensive care situations where using standard monitoring parameters such as ECG, non-invasive blood pressure and pulse oximetry do not provide enough information to enable adequate treatment. The PiCCO Technology provides all the necessary information in an easy to interpret graphical visualization that enables faster therapeutic decisions, based on an array of hemodynamic measurements.

ProAQT sensor supports goal directed therapy and allows the review of interventions to assess their success. The ProAQT monitoring range has been expanded to include variables such as blood flow, volume responsiveness, afterload and contractility. ProAQT Sensor is a special single-use cardiac output sensor, designed for continuous hemodynamic monitoring with suitable PULSION monitors.  The arterial blood pressure curve is utilized to determine the patient's cardiovascular status and to support decisions regarding clinical interventions.

About MAQUET

Maquet, a trusted partner for hospitals and physicians for more than 175 years, is a global leader in medical systems. The company offers innovative therapy solutions and infrastructure capabilities for high-acuity areas within the hospital — including the operating room (OR), hybrid OR/cath lab, and intensive care unit (ICU) — as well as intra- and inter-hospital patient transport. Additionally, Maquet develops intelligent and sustainable room concepts that exceed the expectations of modern hospitals, working in close cooperation with customers, production engineers and architects to integrate high quality products and services.

Headquartered in Rastatt, Germany, Maquet is the largest business area of the publicly listed Getinge Group AB of Sweden. Maquet generated about 1.54 billion Euros in 2013, representing more than half of the Getinge Group's annual revenue of 2.9 billion Euros. Maquet has 6,550 employees and provides over 40 international sales and service organizations, as well as a network of more than 300 sales partners.

www.maquet.com. Maquet – The Gold Standard.

About PULSION

PULSION is a leading provider of specialty monitoring solutions for critically ill patients. The company is particularly strong in cardiac output measurement through its renowned PiCCO and ProAQT brand. PULSION's hemodynamic monitoring can be integrated with most major multi-parameter monitoring solutions. PULSION also provides contrast agents and devices used to enhance visualization in conjunction with surgical and diagnostics procedures.

SOURCE MAQUET